Marsha Cadman - Ryman Healthcare Chief Officer
| RH7 Stock | EUR 2.49 0.01 0.40% |
Insider
Marsha Cadman is Chief Officer of Ryman Healthcare Limited
| Phone | 64 3 366 4069 |
| Web | https://www.rymanhealthcare.co.nz |
Ryman Healthcare Management Efficiency
Ryman Healthcare's management efficiency ratios could be used to measure how well Ryman Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Rick Carron | Superior Plus Corp | N/A | |
| Norman Fitzgerald | NMI Holdings | 56 | |
| Geoffery Merszei | Origin Agritech | 68 | |
| Ingrid Engstrom | SIVERS SEMICONDUCTORS AB | 59 | |
| Hilde Aasheim | Norsk Hydro ASA | 65 | |
| Harry Kanwar | Superior Plus Corp | N/A | |
| AnneLene Midseim | Norsk Hydro ASA | 55 | |
| Mike Taylor | Identiv | N/A | |
| Leigh Dow | Identiv | N/A | |
| Min Tang | Origin Agritech | 61 | |
| Ravi Mallela | NMI Holdings | 53 | |
| John Thuestad | Norsk Hydro ASA | 63 | |
| Dag Sigurd | SIVERS SEMICONDUCTORS AB | 73 | |
| Therese Holm | Norsk Hydro ASA | N/A | |
| Edward Kirnbauer | Identiv | 58 | |
| Steve Dunlap | Identiv | N/A | |
| Hilde Nordh | Norsk Hydro ASA | 54 | |
| Manfred Mueller | Identiv | 53 | |
| Gengchen Han | Origin Agritech | 58 | |
| Justin Scarpulla | Identiv | 50 | |
| Steven Humphreys | Identiv | 62 | |
Management Performance
| Return On Equity | 0.18 | |||
| Return On Asset | -7.0E-4 |
Ryman Healthcare Leadership Team
Elected by the shareholders, the Ryman Healthcare's board of directors comprises two types of representatives: Ryman Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ryman. The board's role is to monitor Ryman Healthcare's management team and ensure that shareholders' interests are well served. Ryman Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ryman Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| MaryAnne Stone, Chief Officer | ||
| Michelle Perkins, Investor Mang | ||
| Cheyne Chalmers, Chief Zealand | ||
| Chris BE, Chief Officer | ||
| David Bennett, Group Officer | ||
| Deborah Marris, G Sec | ||
| Marsha Cadman, Chief Officer | ||
| Cameron Holland, Chief Australia | ||
| Rick Davies, Chief Officer | ||
| Richard Umbers, Group Exec |
Ryman Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ryman Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.18 | |||
| Return On Asset | -7.0E-4 | |||
| Profit Margin | 1.13 % | |||
| Operating Margin | (0.02) % | |||
| Current Valuation | 3.82 B | |||
| Shares Outstanding | 530.46 M | |||
| Shares Owned By Insiders | 11.54 % | |||
| Shares Owned By Institutions | 16.69 % | |||
| Price To Earning | 15.33 X | |||
| Price To Book | 0.93 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Ryman Stock
Ryman Healthcare financial ratios help investors to determine whether Ryman Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ryman with respect to the benefits of owning Ryman Healthcare security.